Moses Bulambo, PMHNP-BC

Moses Bulambo practices at CHRISTUS Health in Alamogordo, New Mexico, part of CHRISTUS Health.

Moses Bulambo's NPI, 1104410331, was assigned on February 28, 2021. Moses Bulambo holds New Mexico license 62667.

Moses Bulambo's primary practice is CHRISTUS Health, at 2669 Scenic Drive, Alamogordo, NM 88310 in Otero County. The practice phone is (575) 439-6100.

Moses Bulambo's primary practice is CHRISTUS Health in Alamogordo, New Mexico, part of CHRISTUS Health. The medical group on file is Luxe Psychiatric and Wellness Services. Dmand AI also links Moses Bulambo to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Moses Bulambo practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatry is Moses Bulambo's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Moses Bulambo is licensed in New Mexico.

CMS data shows 242 Medicare services from Moses Bulambo across 3 procedure codes in 2024, for 33 Medicare patients. Medicare paid $17,305 for them. Every service was in an office.

CMS counts 33 Medicare patients who saw Moses Bulambo in 2024. The largest group is under 65, with 17 patients. 75% of them have anxiety, and 75% have high blood pressure. Their average risk score is 1.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Moses Bulambo's median patient age at 41, with 52% women.

In 2024, Moses Bulambo wrote 839 Medicare Part D claims for 60 patients. 89% of them were for generic drugs. CMS names the drug for 745 of them, across 28 drugs with 11 or more claims each, at $91,544 in total drug cost. In 2023, CMS named 792 claims across 26 drugs.

Moses Bulambo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Moses Bulambo as offering telehealth.

CMS Open Payments shows 11 general payments to Moses Bulambo from 7 drug and device companies from 2021 to 2024. Travel and lodging make up the largest share, 56% of the total. Neuronetics, Inc. paid the most, $1,430.